W. Douglas Biggar

Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study

Craig M. McDonald, Erik Henricson, Richard T. Abresch et al. · The Lancet · 2017 · 446 citations

Long-term Effects, Duchenne Muscular Dystrophy, Degenerative Disease +4

Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade

W. Douglas Biggar, V.A. Harris, L. Eliasoph et al. · Neuromuscular Disorders · 2006 · 367 citations

Deflazacort Treatment, Duchenne Muscular Dystrophy, Pediatrics +3

Influence of hypothermia, barbiturate therapy, and intracranial pressure monitoring on morbidity and mortality after near-drowning

Desmond Bohn, W. Douglas Biggar, C. Smith et al. · Critical Care Medicine · 1986 · 230 citations

Hypertension, Drowning, Severe Cerebral Hypoxia +16

Deflazacort treatment of Duchenne muscular dystrophy

W. Douglas Biggar, Michele Gingras, Darcy Fehlings et al. · The Journal of Pediatrics · 2001 · 214 citations

Duchenne Muscular Dystrophy, Degenerative Disease, Rehabilitation +2

Adolescents with physical disabilities: Some psychosocial aspects of health

S. Elizabeth Stevens, Catherine Steele, Jeffrey W. Jutai et al. · Journal of Adolescent Health · 1996 · 180 citations

Physical Health, Teen Mental Health, Disability +11